The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis

[1]  E. Shevach,et al.  Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. , 1994 .

[2]  D. Enzmann,et al.  Repeated treatment with chimeric anti‐CD4 antibody in multiple sclerosis , 1994, Annals of neurology.

[3]  V. Kuchroo,et al.  Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. , 1993, Journal of immunology.

[4]  A. Pardee,et al.  Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS. NIAID AIDS Clinical Trials Group. , 1993, Journal of acquired immune deficiency syndromes.

[5]  H. Kase,et al.  A new cyclic nucleotide phosphodiesterase isozyme expressed in the T-lymphocyte cell lines. , 1993, Biochemical and biophysical research communications.

[6]  H. Hartung,et al.  Tumor necrosis factor-α in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system , 1993, Journal of Neuroimmunology.

[7]  H. Lassmann,et al.  T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system , 1993, European journal of immunology.

[8]  D. Paty,et al.  Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis , 1993, Neurology.

[9]  S. Endres,et al.  The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells. , 1993, International journal of immunopharmacology.

[10]  N. Suttorp,et al.  Role of phosphodiesterases in the regulation of endothelial permeability in vitro. , 1993, The Journal of clinical investigation.

[11]  P. Duquette,et al.  Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group. , 1993 .

[12]  M. Mclaughlin,et al.  A low-Km, rolipram-sensitive, cAMP-specific phosphodiesterase from human brain. Cloning and expression of cDNA, biochemical characterization of recombinant protein, and tissue distribution of mRNA. , 1993, The Journal of biological chemistry.

[13]  H. Hartung,et al.  Tumor necrosis factor-alpha in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. , 1993, Journal of neuroimmunology.

[14]  P. Tiberghien,et al.  Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease. , 1992, Blood.

[15]  M. Sporn,et al.  Evidence of endogenous regulatory function of transforming growth factor-beta 1 in experimental allergic encephalomyelitis. , 1992, International immunology.

[16]  E. D. Robinson,et al.  Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. , 1992, Journal of immunology.

[17]  梅原 藤雄.  Experimental autoimmune encephalomyelitis in the maturing central nervous system : transfer of myelin basic protein-specific T line lymphocytes to neonatal Lewis rat , 1992 .

[18]  D. McFarlin,et al.  Immunological aspects of demyelinating diseases. , 1992, Annual review of immunology.

[19]  W. Fleischhacker,et al.  A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder. , 1992, Neuropsychobiology.

[20]  R. L. Roper,et al.  A new view of prostaglandin E regulation of the immune response. , 1991, Immunology today.

[21]  E. Benveniste,et al.  Differential tumor necrosis factor alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains , 1991, The Journal of experimental medicine.

[22]  C. Brosnan,et al.  Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. , 1991, The Journal of clinical investigation.

[23]  R. Clark,et al.  An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis , 1990, The Journal of experimental medicine.

[24]  D. Mitchell,et al.  Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. , 1990, International immunology.

[25]  J. Beavo,et al.  Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. , 1990, Trends in pharmacological sciences.

[26]  Y. Qin,et al.  Experimental autoimmune encephalomyelitis in the maturing central nervous system. Transfer of myelin basic protein-specific T line lymphocytes to neonatal Lewis rats. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[27]  H. G. Baumgarten,et al.  Autoradiographic mapping of a selective cyclic adenosine monophosphate phosphodiesterase in rat brain with the antidepressant [3H]rolipram , 1989, Brain Research.

[28]  R. Strieter,et al.  Dynamics of dibutyryl cyclic AMP- and prostaglandin E2-mediated suppression of lipopolysaccharide-induced tumor necrosis factor alpha gene expression , 1989, Infection and immunity.

[29]  N. Geyer,et al.  Rolipram in Major Depressive Disorder: Results of a Double-Blind Comparative Study with Imipramine , 1989, Pharmacopsychiatry.

[30]  W. Krause,et al.  Pharmacokinetics of the antidepressant rolipram in healthy volunteers. , 1989, Xenobiotica; the fate of foreign compounds in biological systems.

[31]  K. Selmaj,et al.  Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro , 1988, Annals of neurology.

[32]  R. Swanborg.  [37] Experimental allergic encephalomyelitis , 1988 .

[33]  R. Swanborg.  Experimental allergic encephalomyelitis. , 1988, Methods in enzymology.

[34]  R. Hirsch,et al.  EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERON , 1987, The Lancet.

[35]  K. Frei,et al.  Antigen presentation and tumor cytotoxicity by interferon‐γ‐treated microglial cells , 1987 .

[36]  K. Frei,et al.  Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. , 1987, European journal of immunology.

[37]  H. Wachtel,et al.  Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors , 1986, Neuropharmacology.

[38]  C. Davis,et al.  Assessment of selective inhibition of rat cerebral cortical calcium-independent and calcium-dependent phosphodiesterases in crude extracts using deoxycyclic AMP and potassium ions. , 1984, Biochimica et biophysica acta.

[39]  I. Cohen,et al.  The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis , 1981, European journal of immunology.

[40]  J. Salk,et al.  Experimental allergic encephalomyelitis. An encephalitogenic basic protein from bovine myelin. , 1969, Archives of biochemistry and biophysics.